secondary immune thrombocytopenia, sITP
Conditions
Interventions
experimental group:sirolimus and dexamethasone
control:steroid
Sponsors
The Second Affiliated Hospital of Army Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 30 x 10^9 / L with severe organ bleeding; 3. Understand the research procedure and voluntarily sign the informed consent in writing.
Exclusion criteria
Exclusion criteria: 1. Severe heart, kidney or liver insufficiency; 2. Women who are pregnant or breastfeeding; 3. Combined with other serious diseases such as hypertension, diabetes, gastric ulcer; 4. Patients with contraindications to the use of hormones and sirolimus; 5. Suffering from lung infection and serious infection in other parts of the body; 6. Those with large wounds or unhealed incisions on the whole body; 7. Those who cannot be followed up as scheduled; 8. The researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Events; | — |
Countries
China
Contacts
Public ContactFeng Yimei
Department of Hematology, Second Affiliated Hospital of Army Military Medical University
Outcome results
None listed